Author

Saad Ebrahim Alobid

Observed name: Saad Alobid
ORCID: 0000-0002-0157-9240
Observed ORCID: 0000-0002-0157-9240
OpenAlex ID: A5081517305
2017 · Ali Alaseem, Khalid Alhazzani, et al. · Seminars in Cancer Biology · 243
2018 · Arkene Levy, Khalid Alhazzani, et al. · Current Cancer Drug Targets · 42
2019 · Thanigaivelan Kanagasabai, Thiagarajan Venkatesan, et al. · Cellular Signalling · 17
2024 · Pradnya V Gadhave, Guruprasad V Sutar, et al. · Saudi Pharmaceutical Journal · 9
2024 · Ziyad Binkhathlan, Osman Yusuf, et al. · International Journal of Pharmaceutics X · 8
2023 · Anjali Nayak, Rashu Raju, et al. · Saudi Pharmaceutical Journal · 8
2023 · Shailaja P. Desai, S.K. Mohite, et al. · Saudi Pharmaceutical Journal · 5
2022 · Khalid Alhazzani, Thiagarajan Venkatesan, et al. · Biotechnology Letters · 4
2025 · Hussam Albassam, Omar Almutairi, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 3
2025 · Riyad F. Alzhrani, Syed Sarim Imam, et al. · Journal of Drug Delivery Science and Technology · 2
2024 · Abdulelah F. Alhusain, Mohamed A. Mahmoud, et al. · Saudi Pharmaceutical Journal · 2
2024 · Anjali Nayak, Rashu Raju, et al. · International Journal of Pharmacology · 2
2026 · Riyad F. Alzhrani, Syed Sarim Imam, et al. · Drug Development and Industrial Pharmacy · 1
2026 · Tahany Saleh Aldayel, Mohamed M. Badran, et al. · Industrial Crops and Products · 1
2024 · Vinay Basavanaka, Mohammed Naseeruddin Inamdar, et al. · International Journal of Pharmacology · 1
2019 · Saad Ebrahim Alobid, Appu Rathinavelu · Cancer Research · 1
Works count: 40
Citation count: 424
H-index: 8
I10-index: 6
Year
Topic
Type